{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-23-000004","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.805430+00:00","generated_at":"2026-06-20T13:31:03.601890+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"Tenet expects FY22 Adj. EBITDA slightly above $3.425B midpoint; CFO to retire","bullets":["Prelim FY22 Adj. EBITDA (ex-pandemic grants) slightly above $3.425B guidance midpoint.","All three business segments met or slightly exceeded their adjusted EBITDA midpoint.","CFO Daniel Cancelmi to retire Dec 31, 2023; national search for successor underway.","USPI CEO Brett Brodnax retiring end of 2023; Andy Johnston expected to take over.","Conifer CEO Roger Davis retiring Q1 2023; multiple internal promotions announced."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-23-000004","json":"https://secwatch.observer/filing/0000070318-23-000004.json","markdown":"https://secwatch.observer/filing/0000070318-23-000004.md","text":"https://secwatch.observer/filing/0000070318-23-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/0000070318-23-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/thc-20230119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T13:31:03.601890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a0c377ddf7609bdd33d2460fe26964d677bc0b34","claim":"TENET HEALTHCARE CORP updated its the fiscal year ended December 31, 2022 guidance (raised).","evidence_excerpt":"On January 19, 2023, Tenet Healthcare Corporation (the “Company”) issued a press release announcing the Company’s expectation that its Adjusted EBITDA, excluding any fourth quarter stimulus grant income related to the pandemic, will beat the midpoint of the Adjusted EBITDA Outlook range for the fiscal year ended December 31, 2022 that was previously disclosed in the Company’s press release dated October 20, 2022 reporting third quarter 2022 results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/0000070318-23-000004-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"65e60578f9","claim":"Daniel Cancelmi departed as Chief Financial Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Daniel Cancelmi, Executive Vice President & Chief Financial Officer, has announced his retirement from the Company, effective December 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/0000070318-23-000004-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"announced retirement"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}